Pharmaceutical sciences researcher with experience in creating biocompatible nanocarriers for targeted drug delivery in cancer. HPLC (Waters, Agilent, and Shimadzu), GC (GC-HS) (Perkin Elmer), and formulation analysis involving stability and drug dissolution investigations are among the areas of expertise. Research interests include bridging strategies for effective therapy outcomes, drug delivery optimization, and nanomedicine.